Patent application number | Description | Published |
20080242610 | POLYPEPTIDES COMPRISING FAS ACTIVATION AND NKG2D-LIGAND DOMAINS - The present invention is drawn to fusion proteins comprising (a) a ligand for an NK receptor and (b) a Fas activation domain, and to nucleic acids encoding such fusion proteins. The invention also includes methods of making and using such proteins and nucleic acids, including their use in preventing or treating cancer. | 10-02-2008 |
20090081789 | Activation of nuclear factor kappa B - The present invention describes a method for targeting a tumor cell comprising contacting the tumor cell with a composition comprising a macrophage and a factor that upregulates nuclear factor-kappa B (NFκB) activity. | 03-26-2009 |
20090087450 | Combination therapy of hybrid cells with BCG injection for treating Cancer Patients - The present invention relates to cancer treatment compositions and methods for a specific cancer patient population. In particular, the application describes methods of treating a patient with cancer, such as a neuroblastoma, with a hybrid cell preparation in combination with | 04-02-2009 |
20090246230 | Compositions and methods for inducing tumor resistance - The invention provides a combined whole cell tumor vaccine for inducing tumor resistance in patients and treating cancer. | 10-01-2009 |
20100047288 | Hybrid cells for treating cancer patients - The present invention relates to cancer treatment compositions and methods for treating a specific cancer patient population. In particular, the application describes methods of treating a patient with cancer, such as a neuroblastoma, with a hybrid cell preparation. | 02-25-2010 |
20100284975 | POLYPEPTIDES COMPRISING FAS ACTIVATION AND NKG2D-LIGAND DOMAINS - The present invention is drawn to fusion proteins comprising (a) a ligand for an NK receptor and (b) a Fas activation domain, and to nucleic acids encoding such fusion proteins. The invention also includes methods of making and using such proteins and nucleic acids, including their use in preventing or treating cancer. | 11-11-2010 |
20130131640 | METHOD OF CREATING AND SORTING FUSED CELLS - An efficient and simplified method for preparing and sorting fused cells is described herein. This approach yields fused cells useful in a variety of applications, including clinical treatment regimens, as cellular modulators of the immune system. | 05-23-2013 |
20140248316 | HYBRID CELLS FOR TREATING CANCER PATIENTS - The present invention relates to cancer treatment compositions and methods for treating a specific cancer patient population. In particular, the application describes methods of treating a patient with cancer, such as a neuroblastoma, with a hybrid cell preparation. | 09-04-2014 |